Non-invasive Measures of Distal Lung Disease in Asthmatics

• Status: Completed
• Trial end date: 2007-09-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a Phase 4, single center study conducted in mild-to moderate asthmatics.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.; Teva Branded Pharmaceutical Products, R&D Inc.
• Treatments: Beclomethasone; Fluticasone Propionate, Salmeterol Xinafoate Drug Combination; Fluticasone-Salmeterol Drug Combination

Criteria

Inclusion Criteria:

• 18-65 years old

• Currently using SABA prn or a low-to-moderate persistent asthma

Exclusion Criteria:

• Tobacco use within 1 year or >= 5 pack years